Evidence map›Paper›PMID 16083803›Full record

ArticleThe Journal of allergy and clinical immunology2005

Does early EBV infection protect against IgE sensitization?

Caroline Nilsson, Annika Linde, Scott M Montgomery, Liselotte Gustafsson, Per Näsman, Marita Troye Blomberg, Gunnar Lilja

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of allergy and clinical immunology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 92 citations in OpenAlex.

  1. The influence of Epstein-Barr virus and cytomegalovirus on childhood respiratory health: A population-based prospective cohort study.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2020
    Trial
  2. Article
  3. Review
  4. Article
  5. Characterization ofViruses · 2024
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Observational
  11. Article
  12. Age at cytomegalovirus, Epstein Barr virus and varicella zoster virus infection and risk of atopy: The Born in Bradford cohort, UK.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2019
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Caroline NilssonDepartment of Pediatrics, Sachs' Children's Hospital, Stockholm South Hospital, Stockholm, Sweden. caroline.nilsson@sodersjukhuset.se
Annika Linde
Scott M Montgomery
Liselotte Gustafsson
Per Näsman
Marita Troye Blomberg
Gunnar Lilja
Karolinska Institutet · SESachs' Children and Youth Hospital · SEKTH Royal Institute of Technology · SEÖrebro University Hospital · SEStockholm University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is indirect evidence that an increased infectious burden is associated with a decreased prevalence of IgE-mediated allergy during childhood.

objectiveTo determine whether there is a relation between the serostatus of 13 different viruses and parentally reported infections and IgE sensitization in 2-year-old children. To investigate whether there is an interaction between cytomegalovirus (CMV) and Epstein-Barr virus (EBV) in relation to IgE sensitization.

methodsA total of 246 infants were followed prospectively to 2 years of age with clinical examinations, skin prick test, and specific IgE analyses and through analysis of seropositivity against adenovirus, influenza, parainfluenza, respiratory syncytial virus, CMV, EBV, herpes simplex virus, human herpesvirus 6, and varicella-zoster virus.

resultsThere was some evidence that IgE sensitization (24%) tended to be more common among children who were seropositive against few compared with children who were seropositive against many viruses, but this was not statistically significant, and there was no consistent trend across the groups. IgE sensitization was statistically significantly less prevalent at 2 years of age among infants who were seropositive against EBV but not other viruses (adjusted odds ratio, 0.34; 95% CI, 0.14-0.86). The interaction of seropositivity against both CMV and EBV antibodies indicated a further reduction in the risk for IgE sensitization (adjusted odds ratio for interaction, 0.10; 95% CI, 0.01-0.92), indicating effect modification associated with seropositivity against CMV.

conclusionOur results indicate that acquisition of EBV infection during the first 2 years of life is associated with a reduced risk of IgE sensitization, and this effect is enhanced by CMV coinfection.

Indexed as

Antibodies, ViralChild, PreschoolCytomegalovirus InfectionsEpstein-Barr Virus InfectionsFemaleHerpesvirus 4, HumanHumansImmunoglobulin EInfantMaleProspective StudiesRespiratory Syncytial Virus InfectionsAntibodies, ViralImmunoglobulin E

Identifiers

PMID16083803
PMCPMC7119037
OpenAlexW2112180350

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.